The Canadian Institutes Of Health Research (CIHR)

Filament Supplies Botanical Psilocybin To Canadian Researchers, Inks Global Licensing Deal

Clinical-stage natural psychedelics company Filament Health (OTCQB: FLHLF) will supply psilocybin for two clinical studies funded by the Canadian Institutes of Health Research (CIHR) operating grants on mental health and Substance Use Disorders (SUDs.)

Canadian State-Funded Trial Looks To Understand If Psychedelia Is Necessary For The Therapeutic Effect Of Psilocybin

Mental health and addiction teaching hospital and research center CAMH has recently been awarded Canada's first federal grant by the Canadian Institutes of Health Research (CIHR) to study psilocybin for treatment-resistant depression.